|
|
Article: Endpoint: agribiotech.
- Article from:
- Instrument Business Outlook
- Article date:
- December 31, 2002
CopyrightCOPYRIGHT 2002 Strategic Directions International Inc. (SDI). This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
As IBO detailed in its cover article in the September 15, 2002 issue, the agribiotech research market, both public and private, is looking more and more to bioinstmmentation techniques as it pursues new genomic and proteomic discoveries. Announcements related to this market continue to demonstrate its opportunities and challenges.
Monsanto and Syngenta have had rough years financially, yet both are still appear committed to genetically modified (GM) products and biotech research. Syngenta and Diversa have formed a new collaboration that will combine their genomic research activities and Syngenta has raised its stake in Diversa to 18%. Also Syngenta Crop Protection ...